 Kalpana Velmurugan
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 127 | 0.470 |
Why?
| | Carcinogenesis | 4 | 2018 | 177 | 0.470 |
Why?
| | Neural Stem Cells | 2 | 2012 | 115 | 0.460 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2011 | 71 | 0.390 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 3 | 2017 | 24 | 0.390 |
Why?
| | Venoms | 1 | 2012 | 30 | 0.390 |
Why?
| | Neuroprotective Agents | 1 | 2012 | 104 | 0.390 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2012 | 101 | 0.380 |
Why?
| | Enzyme Induction | 1 | 2008 | 84 | 0.320 |
Why?
| | Antioxidants | 2 | 2011 | 530 | 0.310 |
Why?
| | Heme Oxygenase-1 | 1 | 2008 | 52 | 0.310 |
Why?
| | Cell Differentiation | 2 | 2012 | 1700 | 0.310 |
Why?
| | Stem Cells | 1 | 2012 | 545 | 0.300 |
Why?
| | Signal Transduction | 7 | 2019 | 4509 | 0.290 |
Why?
| | Peptides | 1 | 2012 | 848 | 0.270 |
Why?
| | Hypoxia | 1 | 2012 | 957 | 0.250 |
Why?
| | Cytokines | 1 | 2012 | 1840 | 0.230 |
Why?
| | Anthracenes | 3 | 2019 | 27 | 0.230 |
Why?
| | Apoptosis | 2 | 2012 | 2362 | 0.220 |
Why?
| | Lung | 6 | 2018 | 3558 | 0.200 |
Why?
| | Cell Line | 5 | 2019 | 2635 | 0.200 |
Why?
| | Fluorenes | 2 | 2019 | 38 | 0.200 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2177 | 0.170 |
Why?
| | Printing | 1 | 2019 | 4 | 0.170 |
Why?
| | Paper | 1 | 2019 | 8 | 0.170 |
Why?
| | Eicosanoids | 1 | 2019 | 54 | 0.160 |
Why?
| | Glutathione | 2 | 2011 | 293 | 0.160 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.150 |
Why?
| | Mucin 5AC | 1 | 2018 | 48 | 0.150 |
Why?
| | Air Pollution, Indoor | 1 | 2019 | 108 | 0.150 |
Why?
| | Particulate Matter | 1 | 2019 | 185 | 0.150 |
Why?
| | Environmental Monitoring | 1 | 2019 | 254 | 0.140 |
Why?
| | Carcinogens | 1 | 2017 | 103 | 0.140 |
Why?
| | Mitogens | 1 | 2017 | 58 | 0.140 |
Why?
| | Inflammation | 3 | 2017 | 2477 | 0.140 |
Why?
| | Promoter Regions, Genetic | 2 | 2012 | 1131 | 0.130 |
Why?
| | Insulin-Secreting Cells | 2 | 2012 | 317 | 0.130 |
Why?
| | Air Pollutants | 1 | 2019 | 242 | 0.130 |
Why?
| | Epiregulin | 1 | 2016 | 2 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2012 | 3881 | 0.130 |
Why?
| | Pulmonary Alveoli | 1 | 2017 | 373 | 0.120 |
Why?
| | Mice | 8 | 2018 | 14860 | 0.120 |
Why?
| | Mice, Inbred BALB C | 4 | 2019 | 1143 | 0.120 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 217 | 0.120 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 260 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 287 | 0.110 |
Why?
| | Adenocarcinoma | 2 | 2016 | 795 | 0.100 |
Why?
| | Animals | 10 | 2019 | 31694 | 0.100 |
Why?
| | Connexin 43 | 3 | 2017 | 23 | 0.100 |
Why?
| | Response Elements | 2 | 2011 | 82 | 0.100 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2012 | 56 | 0.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2012 | 106 | 0.100 |
Why?
| | Chalcone | 1 | 2011 | 2 | 0.100 |
Why?
| | Gap Junctions | 3 | 2017 | 58 | 0.090 |
Why?
| | Neural Pathways | 1 | 2012 | 261 | 0.090 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 144 | 0.090 |
Why?
| | Enzyme Activation | 3 | 2019 | 785 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1141 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 720 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 961 | 0.090 |
Why?
| | Mice, Nude | 1 | 2012 | 630 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 1842 | 0.080 |
Why?
| | Pancreas | 1 | 2012 | 276 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 2012 | 255 | 0.080 |
Why?
| | Drugs, Chinese Herbal | 1 | 2008 | 13 | 0.080 |
Why?
| | Curcumin | 1 | 2008 | 28 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 110 | 0.080 |
Why?
| | Drug Synergism | 1 | 2008 | 316 | 0.070 |
Why?
| | Protein Kinase C-delta | 1 | 2008 | 70 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2319 | 0.070 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 164 | 0.070 |
Why?
| | Computer Simulation | 1 | 2012 | 872 | 0.070 |
Why?
| | Herpesvirus 3, Human | 1 | 2011 | 378 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 329 | 0.070 |
Why?
| | Pharmaceutical Preparations | 1 | 2008 | 165 | 0.070 |
Why?
| | Molecular Weight | 2 | 2019 | 331 | 0.070 |
Why?
| | Butylated Hydroxytoluene | 2 | 2016 | 31 | 0.070 |
Why?
| | Islets of Langerhans | 1 | 2012 | 726 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2008 | 554 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2017 | 278 | 0.060 |
Why?
| | Cell Communication | 2 | 2017 | 279 | 0.060 |
Why?
| | Neurons | 1 | 2011 | 1279 | 0.050 |
Why?
| | Humans | 9 | 2019 | 114623 | 0.050 |
Why?
| | Phosphorylation | 2 | 2019 | 1569 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2017 | 950 | 0.050 |
Why?
| | Graphite | 1 | 2019 | 11 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 45 | 0.040 |
Why?
| | Metals | 1 | 2019 | 106 | 0.040 |
Why?
| | Particle Size | 1 | 2019 | 317 | 0.040 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2017 | 5 | 0.040 |
Why?
| | DNA Adducts | 1 | 2017 | 15 | 0.040 |
Why?
| | Benzo(a)pyrene | 1 | 2017 | 7 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 151 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 228 | 0.040 |
Why?
| | Male | 4 | 2018 | 55554 | 0.030 |
Why?
| | Mutation | 2 | 2018 | 3344 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6112 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 807 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 84 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 2710 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1211 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2018 | 554 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 216 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 521 | 0.030 |
Why?
| | Gene Deletion | 1 | 2016 | 356 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 1947 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1040 | 0.030 |
Why?
| | Transcriptome | 1 | 2017 | 725 | 0.020 |
Why?
| | Cell Death | 1 | 2013 | 322 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 15 | 0.020 |
Why?
| | Virology | 1 | 2011 | 19 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2011 | 80 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1421 | 0.020 |
Why?
| | Metalloporphyrins | 1 | 2011 | 103 | 0.020 |
Why?
| | Pneumonia | 1 | 2016 | 567 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3328 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 397 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 162 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2011 | 337 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1261 | 0.020 |
Why?
| | Viral Proteins | 1 | 2011 | 281 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 531 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 785 | 0.020 |
Why?
| | Fibroblasts | 1 | 2011 | 837 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2011 | 1076 | 0.020 |
Why?
| | Female | 1 | 2018 | 59466 | 0.010 |
Why?
|
|
Velmurugan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|